Children's cough syrup recalled over bacteria concerns
Medtech Products Inc. is recalling five lots of Little Remedies Honey Cough Syrup due to the presence of Bacillus cereus, as well as the 'loss of shelf-stability,' the company explained.
The recalled products were distributed nationwide. They were sold 4-ounce bottles, both in stores and online, between Dec. 14, 2022, and June 4, 2025.
Identifying information, including the UPC and lot numbers, as well as the expiration dates, can be found below:
No other Little Remedies products were included in the recall.
While no serious adverse events have been reported in connection to the cough syrup, the FDA warns that Bacillus cereus can cause short-term illness and, in some cases, lead to death.
Bacillus cereus, or B. cereus, is a spore-forming bacterium that commonly exists in our environment, the Cleveland Clinic explains. Exposure to the toxin it creates can result in one of two types of illness — one described as a diarrheal syndrome and another as a vomiting syndrome. The first is characterized by cramps and watery diarrhea, while the second more commonly causes nausea and vomiting.
In severe cases, Bacillus cereus infection can lead to death.
Those who believe they may be suffering from an illness caused by Bacillus cereus are urged to contact a healthcare provider.
Customers who purchased the recalled Little Remedies cough syrup are being told to discard the product. Those with questions or refund requests can reach Medtech at 1-800-754-8853, by email at medicalaffairs@prestigebrands.com, or through the company's website.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NBC News
2 hours ago
- NBC News
FDA warns about unapproved thyroid pills — then says it'll 'ensure access' to them
An unusual about-face that played out at the Food and Drug Administration over the last week illustrated the power of the 'Make America Healthy Again' movement, particularly with its focus on 'natural' drugs. Last Thursday, the agency published a statement saying it had concerns about the safety and effectiveness of unapproved thyroid medications made from animal tissue after it received complaints from patients and reports of adverse events. As a result, the FDA said it had notified drugmakers of its 'intent to take action' against the products, but added that it wouldn't do so immediately to give patients time to switch medications. 'The agency urges patients taking these unapproved animal-derived thyroid medications to treat hypothyroidism to talk to their doctor,' it wrote. The statement in and of itself was nothing surprising. Warnings about unapproved drugs are standard fare for the FDA. What followed also wasn't unheard of: social media backlash. But on Wednesday evening, FDA Commissioner Marty Makary seemingly reversed course, writing in a post on X that the FDA was committed to pursuing the first-ever approval of desiccated thyroid extract, pending results of the ongoing clinical trials. 'In the mean time, we will ensure access for all Americans,' he wrote. Five minutes later, Health Secretary Robert F. Kennedy Jr. responded. 'Love your approach of using gold standard science and common sense, @DrMarkaryFDA,' Kennedy wrote. So, what was this all about? Animal-derived thyroid pills The thyroid — a small, butterfly-shaped gland located at the front of the neck — helps regulate how the body uses energy by producing thyroid hormones. When it doesn't produce enough, it can lead to hypothyroidism, which can cause symptoms including unexplained weight gain, tiredness, sensitivity to cold, changes in menstrual cycles and symptoms of depression and anxiety, according to the Mayo Clinic. The condition is more common in women than men. The standard treatment is prescription thyroid hormone replacement therapy — basically, taking pills that contain the needed thyroid hormones. Typically one of two synthetic hormones, levothyroxine or liothyronine, or a combination of both, are prescribed. Some patients, however, turn to animal-derived thyroid pills either because they don't respond well to the synthetic versions or want to take something marketed as natural, said Dr. Michael Weintraub, an endocrinologist at NYU Langone Health in New York City. The pills — which aren't FDA-approved — are made from dried thyroid glands, usually from pigs, and are sold under brand names like Armour Thyroid, NP Thyroid, Nature-Thyroid and Natural Thyroid, according to the agency. About 1.5 million people in the U.S. were prescribed animal-derived thyroid pills in 2024, the FDA said. In the FDA statement warning against the animal-derived drugs, the agency said they may contain impurities that could result in infections and could also contain inconsistent levels of thyroid hormones, another risk for patients. Taking too much can cause unwanted effects, the FDA said, and too little could not be effective. The backlash In the days that followed the FDA's statement, patients and doctors took to social media to voice their opposition. 'BREAKING FDA set to BAN natural desiccated thyroid medications. Millions rely on these for hypothyroidism who don't respond well to synthetic thyroid pharmaceuticals,' read one post from Will Cole, a functional medicine doctor. 'Let your voice be heard. The FDA needs to change course on this one.' Dave Asprey, the founder of Bulletproof Coffee, a coffee and supplement brand, wrote: 'I found out I had very low thyroid levels in my mid-20s, and Hashimoto's. Normal synthetic thyroid drugs did not work. Natural thyroid extract worked very well and I have been taking it for more than 25 years without a problem.' Dr. Robert Malone — an anti-vaccine activist who was recently appointed by Kennedy to a vaccine advisory panel — called the decision 'terrible news — particularly for postmenopausal women.' He called on doctors and patients to contact the FDA in response. Andrew Nixon, a spokesperson for the Department of Health and Human Services, did not respond to a question about whether Makary's post on Wednesday was in response to social media backlash. When asked about whether the FDA would still take action against unapproved thyroid products, Nixon referred NBC News to the agency's statement last week, which said, 'FDA is not taking immediate action against manufacturers who make unapproved animal-derived thyroid medication to give patients time to transition to an FDA-approved medication to treat their hypothyroidism.' Nixon added that the agency 'will share additional information as it becomes available and as clinical trial results are released.' It's unclear which ongoing trials Makary and Nixon were referring to. lists a trial initiated by Walter Reed National Military Medical Center in 2012, but the trial's status is currently marked as 'unknown.' Allergan, the maker of Armour Thyroid, completed a trial in 2021 comparing its product to levothyroxine, a synthetic thyroid hormone. So, are these pills safe? Dr. Pieter Cohen, an associate professor of medicine at Harvard Medical School, said the FDA was correct to issue its initial warning about the thyroid pills, noting that the animal-derived pills aren't regulated by the agency and can pose significant risks. The FDA-approved synthetic versions usually replace one of two thyroid hormones: T4, the main hormone the thyroid produces, or T3, the active form of T4 that helps regulate energy and metabolism. Companies that make FDA-approved drugs must follow certain regulations, including consistent dosing. The animal-derived versions also contain the thyroid hormones, just like prescription medications, Cohen said, but because they're unregulated, the amount they contain can be all over the place. 'Getting too much or too little thyroid hormone has long-term health risks,' he said. 'If you take too much, it can damage your bones, it can damage your heart. If you take too little, if you're not getting enough, a number of problems can occur too, including mood problems, like depression.' Weintraub, of NYU Langone Health, said that tiny changes in thyroid hormone levels can have a big impact, so it's important to get the dosage right. He noted that pigs naturally have much higher levels of T3 than humans. 'It can lead to heart rhythm disturbances, which can be life-threatening. It can lead to bone degradation, which can lead to broken bones,' he said. Weintraub said he's had patients who took animal-derived thyroid pills who've had issues with sleeping, had sensitivity to heat or developed osteoporosis. Dr. Susan Spratt, an endocrinologist and senior medical director for the Population Health Management Office at Duke Health in North Carolina, however, said that it would be unfair for the FDA to 'suddenly yank' the animal-derived versions from the market 'without dedicated reasons that they are harmful.' Spratt said that the animal-derived pills have been around for decades as a prescribable drug. (Weintraub said the animal-derived drugs were 'grandfathered in,' meaning they were already on the market before current FDA standards for safety were put into place.) While Spratt said she prefers to prescribe the FDA-approved synthetic versions, the animal-derived versions offer an option for people who don't respond well to the synthetic ones. 'I would welcome NIH funding on why some patients don't feel as good on T4-only products,' she said. Weintraub said the synthetic versions don't 'necessarily help everyone's symptoms, but there's a more precise and safer way of treating that than resorting to a pig or cow thyroids.' He said patients who don't respond well to T4- or T3-only medications often do better on a combination of the two.
USA Today
5 hours ago
- USA Today
FDA warns this cookware could be leaching lead into your food
Cookware that is likely still on shelves could be leaching lead into your food, the Food and Drug Administration said in an Aug. 13 warning. The FDA became aware of the issue after testing pots made by an Indian manufacturer and finding that they were made with Hindalium/Hindolium or Indalium/Indolium, metal alloys that are made from aluminum, aluminum alloys and brass. These substances are common in some types of imported cookware, said the FDA, but are not used in the U.S. due to their tendency to leach lead into food cooked or stored within. There is no known level of lead exposure that is considered safe and some people are at even higher risk of adverse effects, warned the agency, including young children, people of child-bearing age and people who are breastfeeding. Here's what to know. Which cookware is included in the warning? The FDA identified the manufacturer, an Indian aluminum cookware company called Saraswati Strips Pvt. Ltd that sells products under the brand name Tiger White. However, it was unable to contact a distributor to initiate a recall, meaning the impacted products are not being pulled from shelves on a large scale. Impacted products are Kadais/Karahis, or deep pots used for simmering and frying, with brand name Tiger White. The FDA tested two specific items at a Mannan Supermarket in Jamaica, New York, labeled "Pure Aluminium Utensils Tiger White RTM No: 2608606 An ISO 9001:2015 Certified Co. Saraswati Strips Pvt. Ltd. India." However, the FDA warns that these are not the only potentially affected products and more could be added as the investigation continues. What to do if you have an impacted product Consumers should check their homes for any listed products or similar cookware and throw them away. They should not attempt to refurbish or repair the cookware. If you are concerned about possible lead exposure, the FDA advises contacting your health care provider. Retailers and distributors are responsible for ensuring the safety of cookware they sell, said the FDA, meaning those that may have the affected products on the market should use the FDA's lead leach testing protocol for cookware or another testing method. They are also encouraged to consult with the FDA on the updated safety and regulatory status of food-related products. Questions for the FDA related to this topic can be sent to premarkt@ What is the risk of lead exposure? The FDA does not allow the use of lead in products related to food, including components of cookware and other food contact surfaces. Lead is toxic to humans and can be ingested when a product like the cookware leaches it into items it comes into contact with. Even low levels of exposure are linked to serious health issues, including fatigue, headache, stomach pain, vomiting or neurologic changes, according to the FDA. Exposure is especially dangerous to developing fetuses and children, potentially causing learning difficulties, low IQ and behavioral changes. Even when they don't show obvious symptoms, babies and children can be permanently impacted by elevated levels of lead in their blood, especially due to their smaller size and metabolism.
The Hill
7 hours ago
- The Hill
Federal judge blocks Trump administration's broad birth control mandate exemptions
The Trump administration's religious and moral carve-outs to an ObamaCare requirement that all employer health plans cover contraception at no cost were blocked on Wednesday by a federal judge. District Judge Wendy Beetlestone in Philadelphia issued a summary judgment that the rules were arbitrary, capricious and an overreach of the authority of the agencies that wrote them in 2017. Under the rules, essentially any for-profit or nonprofit employer or insurer was allowed to exempt themselves from following the birth control mandate on moral and religious grounds. The rules also let publicly traded companies obtain a religious exemption, but not a moral one. The Affordable Care Act required employer health plans to cover at least one of 18 forms of birth control approved by the Food and Drug Administration. Religious groups and employers sued, and the Supreme Court in 2014 ruled 5-4 that the contraceptive mandate violated the Religious Freedom Restoration Act (RFRA) rights of closely held corporations whose owners had religious objections. Subsequent agency actions tried to find a balance, but the Trump administration in 2017 issued a blanket exemption. The rules didn't require employers to apply for an exemption because the administration said that would be a violation of their religious rights. Pennsylvania, New Jersey and dozens of other states sued to halt that broad expansion of exemptions and accommodations. That lawsuit reached the Supreme Court in 2020, where the justices upheld the Trump rules on technical grounds but did not address the underlying merits of the case. The case was sent back to the lower court, where a religious group, Little Sisters of the Poor, joined the lawsuit alongside the federal government in asking for summary judgment. Beetlestone, an appointee of former President Obama, wrote that the Trump administration's religious rule did not accomplish what the agencies purportedly wrote it to do, which was to resolve a conflict between the contraceptive mandate and RFRA. But the rule exemptions to organizations that are 'unlikely, if ever, to be capable of maintaining a religious objection, raising further doubts as to any 'rational connection' between the Rule and remedying potential conflicts with RFRA,' Beetlestone wrote. The Little Sisters of the Poor will appeal the ruling in the coming weeks, according to the Becket Fund for Religious Liberty, a nonprofit that represents the order.
